133 related articles for article (PubMed ID: 37478915)
1. Ligand-installed polymeric nanocarriers for combination chemotherapy of EGFR-positive ovarian cancer.
Xi X; Lei F; Gao K; Li J; Liu R; Karpf AR; Bronich TK
J Control Release; 2023 Aug; 360():872-887. PubMed ID: 37478915
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable hybrid polymer micelles for combination drug therapy in ovarian cancer.
Desale SS; Cohen SM; Zhao Y; Kabanov AV; Bronich TK
J Control Release; 2013 Nov; 171(3):339-48. PubMed ID: 23665258
[TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of platinum-taxane combination therapy in ovarian cancer.
Desale SS; Soni KS; Romanova S; Cohen SM; Bronich TK
J Control Release; 2015 Dec; 220(Pt B):651-9. PubMed ID: 26381902
[TBL] [Abstract][Full Text] [Related]
4. LHRH-targeted nanogels as a delivery system for cisplatin to ovarian cancer.
Nukolova NV; Oberoi HS; Zhao Y; Chekhonin VP; Kabanov AV; Bronich TK
Mol Pharm; 2013 Oct; 10(10):3913-21. PubMed ID: 23957812
[TBL] [Abstract][Full Text] [Related]
5. Polypeptide nanogels with hydrophobic moieties in the cross-linked ionic cores: synthesis, characterization and implications for anticancer drug delivery.
Kim JO; Oberoi HS; Desale S; Kabanov AV; Bronich TK
J Drug Target; 2013 Dec; 21(10):981-93. PubMed ID: 23998716
[TBL] [Abstract][Full Text] [Related]
6. Development of EGFR-targeted polymer blend nanocarriers for combination paclitaxel/lonidamine delivery to treat multi-drug resistance in human breast and ovarian tumor cells.
Milane L; Duan Z; Amiji M
Mol Pharm; 2011 Feb; 8(1):185-203. PubMed ID: 20942457
[TBL] [Abstract][Full Text] [Related]
7. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo.
Chen J; Ouyang J; Chen Q; Deng C; Meng F; Zhang J; Cheng R; Lan Q; Zhong Z
ACS Appl Mater Interfaces; 2017 Jul; 9(28):24140-24147. PubMed ID: 28675028
[TBL] [Abstract][Full Text] [Related]
8. Degradable cisplatin-releasing core-shell nanogels from zwitterionic poly(beta -aminoester)-graft-PEG for cancer chemotherapy.
Jin W; Xu P; Zhan Y; Shen Y; Van Kirk EA; Alexander B; Murdoch WJ; Liu L; Isaak DD
Drug Deliv; 2007 Jul; 14(5):279-86. PubMed ID: 17613015
[TBL] [Abstract][Full Text] [Related]
9. Cationic versus anionic core-shell nanogels for transport of cisplatin to lung cancer cells.
Gonzalez-Urias A; Zapata-Gonzalez I; Licea-Claverie A; Licea-Navarro AF; Bernaldez-Sarabia J; Cervantes-Luevano K
Colloids Surf B Biointerfaces; 2019 Oct; 182():110365. PubMed ID: 31344612
[TBL] [Abstract][Full Text] [Related]
10. Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer.
Cho H; Lai TC; Kwon GS
J Control Release; 2013 Feb; 166(1):1-9. PubMed ID: 23246471
[TBL] [Abstract][Full Text] [Related]
11. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo.
Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS
Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491
[TBL] [Abstract][Full Text] [Related]
12. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-bonded cytosine-endowed supramolecular polymeric nanogels: Highly efficient cancer cell targeting and enhanced therapeutic efficacy.
Fan WL; Huang SY; Yang XJ; Bintang Ilhami F; Chen JK; Cheng CC
J Colloid Interface Sci; 2024 Jul; 665():329-344. PubMed ID: 38531278
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of Vorinostat and Etoposide Via Disulfide Cross-Linked Biodegradable Polymeric Nanogels: Synthesis, Characterization, Biodegradation, and Anticancer Activity.
Kumar P; Wasim L; Chopra M; Chhikara A
AAPS PharmSciTech; 2018 Feb; 19(2):634-647. PubMed ID: 28948528
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-triggered- and tumor-targeted delivery with tunable, methacrylated poly(ethylene glycols) and hyaluronic acid hybrid nanogels.
Liwinska W; Waleka-Bagiel E; Stojek Z; Karbarz M; Zabost E
Drug Deliv; 2022 Dec; 29(1):2561-2578. PubMed ID: 35938558
[TBL] [Abstract][Full Text] [Related]
16. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy.
Zhang G; Liu F; Jia E; Jia L; Zhang Y
Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled nanoscale coordination polymers carrying siRNAs and cisplatin for effective treatment of resistant ovarian cancer.
He C; Liu D; Lin W
Biomaterials; 2015 Jan; 36():124-33. PubMed ID: 25315138
[TBL] [Abstract][Full Text] [Related]
18. PEG-b-poly (carbonate)-derived nanocarrier platform with pH-responsive properties for pancreatic cancer combination therapy.
Ray P; Confeld M; Borowicz P; Wang T; Mallik S; Quadir M
Colloids Surf B Biointerfaces; 2019 Feb; 174():126-135. PubMed ID: 30447521
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a Hybrid System Containing an Alginic Acid-Based Nanogel and an
Yamaguchi K; Hiraike O; Iwaki H; Matsumiya K; Nakamura N; Sone K; Ohta S; Osuga Y; Ito T
Mol Pharm; 2021 Nov; 18(11):4090-4098. PubMed ID: 34662129
[TBL] [Abstract][Full Text] [Related]
20. Folate-decorated nanogels for targeted therapy of ovarian cancer.
Nukolova NV; Oberoi HS; Cohen SM; Kabanov AV; Bronich TK
Biomaterials; 2011 Aug; 32(23):5417-26. PubMed ID: 21536326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
